International Updates

Germany’s Cannabis Act (CanG) is beginning to transform the country's medical cannabis market, with potential opportunities to expand telemedicine, improve physician training, and enhancing accessibility in this rapidly growing industry.

In reversal of recent developments, officials in Thailand have signaled that cannabis will not be re-criminalized.

The Cannabis for Private Purposes Act legalizes cannabis for adults while prohibiting public consumption, sales, and detailing measures for protecting children.

At the Cannabis Science Conference Spring 2024, toxicologist Cristelle Santos provided a deep dive into the need for better cannabis product safety standards.

This hour-long webinar covered consumer safety, interstate commerce, and the need for global standards, highlighting collaboration and evidence-based approaches for future regulatory frameworks.

The contrast between cannabis for medical and recreational use in Canada since their respective legalizations.

Less than two years after recreational cannabis was legalized, officials disclose new details of legislation restricting its use once more.

On February 23, 2024, recreational cannabis became legal in Germany in certain capacities.

ASTM International’s upcoming conference presents an opportunity to make an impact in global cannabis companies and industries.

A cannabis company in Jamaica has announced its first exportation of some of its products to the US.

Approval of legislation this week would allow cannabis possession to begin within months.

Germany is on the path to legalize recreational cannabis this year, but challenges are surfacing.

A recent vote will place the bill before the president for final approval.

Ireland opens up their first medical cannabis clinic.

To help the mental health of citizens and soldiers, the president of Ukraine called for more support for medical cannabis legalization in the country.

The Nova Scotia House of Assembly recently heard a petition to cover the cost of CBD-based medications for certain conditions.

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.